← Open Payments lookup

ASHLEIGH EBRENEYIN: Open Payments

NPI 1235872375 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,311 in 101 payments from 21 companies in 2025. Trend: 2023 $1,260 · 2024 $1,613 · 2025 $2,311

Food & beverage: $2,311
CompanyPaymentsAmount
ABBVIE INC.19$384
Salix Pharmaceuticals, a division of Bausch Health US, LLC15$312
PFIZER INC.10$248
QOL Medical, LLC8$215
Takeda Pharmaceuticals U.S.A., Inc.9$204
Lilly USA, LLC4$125
Janssen Biotech, Inc.4$111
GENZYME CORPORATION4$109
Ipsen Biopharmaceuticals, Inc4$102
Madrigal Pharmaceuticals5$99

Products named: XIFAXAN, Sucraid, VELSIPITY, RINVOQ, LINZESS, DUPIXENT, OMVOH, TREMFYA.

Industry payments across DC — which companies pay providers there.